首页> 外文期刊>Molecular Psychiatry >Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands
【24h】

Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands

机译:法罗群岛患者4p16号染色体上双相情感障碍和精神分裂症的常见危险源的可能证据

获取原文
       

摘要

Patients with schizophrenia (n=11) and bipolar affective disorder (n=17) from the relatively isolated population of the Faroe Islands were genotyped for 34 polymorphic markers on chromosome 4 in a search for allelic association and haplotype sharing among distantly related patients. When considering bipolar patients only, there was no clearcut support for any region on chromosome 4. The two-marker segment D4S394–D4S2983 at 4p16.1 was, however, supported by a P-value of 0.0162. For patients with schizophrenia, there was reasonable support for 4p16.1 as marker D4S2281 (P=0.0019), a two-marker segment (D4S2281–D4S1605, P=0.0009) and a three-marker segment (D4S2923–D4S2928–D4S1582, P–0.0005) appeared to be associated with schizophrenia, with some alleles/haplotypes occurring with different frequencies in patients compared to controls. When combining both psychiatric disorders, chromosome 4p16.1 received further support from five partially overlapping two- and three-marker segments (D4S394–D4S2983, P=0.0039; D4S2281–D4S1605, P=0.0027 and D4S394–D4S2983–D4S2923, P=0.006; D4S2923–D4S2928–D4S1582, P=0.00007; D4S1582–D4S1599–D4S2281, P=0.005). Increased haplotype sharing in patients with schizophrenia and in the combined data set was partly supported by Fisher's exact test and tests based on the genealogy. Our study yields support for a common risk gene for schizophrenia and bipolar affective disorder on the short arm of chromosome 4, as suggested by previous findings in the neighbouring Scottish population.
机译:在法罗群岛相对分离的人群中,患有精神分裂症(n = 11)和双相情感障碍(n = 17)的患者在第4号染色体上针对34个多态性标记进行了基因分型,以寻找远距离相关患者之间的等位基因关联和单倍型共享。仅考虑双相情感障碍患者时,第4号染色体上的任何区域都没有明确的支持。但是,在4p16.1处的两个标记片段D4S394–D4S2983受P值0.0162支持。对于精神分裂症患者,合理支持4p16.1作为标记D4S2281(P = 0.0019),两个标记段(D4S2281-D4S1605,P = 0.0009)和三个标记段(D4S2923–D4S2928–D4S1582,P –0.0005)似乎与精神分裂症有关,与对照组相比,患者中的某些等位基因/单倍型发生频率不同。当合并两种精神疾病时,染色体4p16.1得到了五个部分重叠的两个和三个标记部分的进一步支持(D4S394–D4S2983,P = 0.0039; D4S2281-D4S1605,P = 0.0027和D4S394–D4S2983–D4S2923,P = 0.006 ; D4S2923–D4S2928–D4S1582,P = 0.00007; D4S1582–D4S1599–D4S2281,P = 0.005)。 Fisher的精确检验和基于家谱的检验部分支持了精神分裂症患者和组合数据集中单倍型共享的增加。我们的研究为第4号染色体短臂上的精神分裂症和双相情感障碍的常见风险基因提供了支持,这在邻近的苏格兰人群中已有发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号